CARDIOVASCULAR
hamburger

Advanced Heart Failure Today

OVER 6.2 MILLION adults in the United States have heart failure.1

Heart failure is a complex, progressive disease that can be challenging to manage.2,3 It is associated with a markedly poor prognosis and significantly reduced quality of life, leading to increased risk of death.2,3

The mortality rate for heart failure

INCREASED BY 24%4
(between 2011-2017)

Patients hospitalized for heart failure have a

Median Survival of < 2.4 Years5

Heart failure in the United States is attributed to

Over 350,000 Deaths Per Year4

Today, left ventricular assist devices (LVADs) are making a better future possible for many patients with advanced heart failure.6

Advanced Therapies

Clinicians play a critical role in identifying heart failure progression early enough to help prevent heart failure-related hospitalizations, improve quality of life and extend survival for patients.

Even with optimal medical management, medications can become less effective as heart failure progresses. It’s important to recognize when medications alone are not enough, and advanced therapies need to be considered.3

Fortunately, continuous innovation is creating more options for patients with advanced heart failure, offering more hope for better lives.

Heart transplantation continues to be limited by the shortage of donor hearts or wait times.7 With HeartMate 3 LVAD outcomes, LVAD therapy can be considered for more patients with advanced heart failure.6

Sisters

  • Manuals & Resources
  • Find a HeartMate 3 LVAD Center
  • Customer Service

References

  1. Virani S, Alonso A, Benjamin E, et al. Heart Disease and Stroke Statistics-2020 Update. Circulation. 2020;141(9):e139-e596.
  2. Rogers JG, Pagani F, Tatooles A, et al. Intrapericardial left ventricular assist device for advanced heart failure. New Engl J Med. 2017;376:451-460.
  3. AbouEzzeddine OF, Redfield MM. Who has advanced heart failure? Definition and epidemiology. Congest Heart Fail. 2011;17:1-18.
  4. Sidney S, Go A, Jaffe M, Solomon MD, et al. Association between aging of the US population and heart disease mortality from 2011 to 2017. JAMA Cardiol. 2019;1:1280-1286.
  5. Setoguchi S, Stevenon LW, Schneeweiss S. Repeated hospitalizations predict mortality in the community population with heart failure. Am Heart J. 2009;154:260-266.
  6. Mehra M, Uriel N, Naka Y, et al. A Fully Magnetically Levitated Left Ventricular Assist Device-Final Report. N Engl J Med. 2019;380:1618-1627.
  7. Hscich, EM. Matching the Market for Heart Transplantation. Circ Heart Fail. 2016;9:e002679.
Indications, Safety & Warnings

MAT-2012368 v1.0

DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?

CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.

False
accessibility
© 2019 Abbott. All Rights Reserved. Please read the Legal Notice for further details.

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

accessibility

DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?

CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.